{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:12:08Z","timestamp":1775470328628,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jaad.2014.10.012","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T12:17:52Z","timestamp":1421410672000},"page":"712-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Promising alternative clinical uses of prostaglandin F2\u03b1 analogs: Beyond the eyelashes"],"prefix":"10.1016","volume":"72","author":[{"given":"Young M.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Levins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaad.2011.06.005","article-title":"Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study","volume":"66","author":"Smith","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2014.10.012_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/archopht.1997.01100160376025","article-title":"Latanoprost and hyperpigmentation of eyelashes","volume":"115","author":"Wand","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.118.5.718","article-title":"Eyelash formation secondary to latanoprost treatment in a patient with alopecia","volume":"118","author":"Mansberger","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"5 Suppl","key":"10.1016\/j.jaad.2014.10.012_bib4","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.jaad.2004.05.002","article-title":"Hypertrichosis of the eyelashes caused by bimatoprost","volume":"51","author":"Tosti","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2014.10.012_bib5","first-page":"614","article-title":"Latanoprost and periocular skin changes","volume":"119","author":"Wand","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.jaad.2014.10.012_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archopht.123.11.1609","article-title":"Periocular cutaneous pigmentary changes associated with bimatoprost use","volume":"123","author":"Galloway","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.jaad.2014.10.012_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archophthalmol.2010.89","article-title":"Latisse-induced periocular skin hyperpigmentation","volume":"128","author":"Priluck","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.jaad.2014.10.012_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15569520903232534","article-title":"Extensive facial skin pigmentation after latanoprost treatment","volume":"28","author":"Chien","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"issue":"10","key":"10.1016\/j.jaad.2014.10.012_bib9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archopht.125.10.1427","article-title":"Severe darkening of a facial skin graft from latanoprost","volume":"125","author":"Calladine","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jaad.2014.10.012_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1468-3083.2006.01911.x","article-title":"Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes","volume":"21","author":"Feletti","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2014.10.012_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archopht.116.8.1065","article-title":"Prostaglandin-induced iris color darkening","volume":"116","author":"Zhan","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00061198-200110000-00008","article-title":"Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients","volume":"10","author":"Chiba","year":"2001","journal-title":"J Glaucoma"},{"issue":"7","key":"10.1016\/j.jaad.2014.10.012_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.eye.6701663","article-title":"Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes","volume":"19","author":"Chou","year":"2005","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10384-003-0039-6","article-title":"A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost","volume":"48","author":"Chiba","year":"2004","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jaad.2014.10.012_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1600-0749.2000.130305.x","article-title":"Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys","volume":"13","author":"Prota","year":"2000","journal-title":"Pigment Cell Res"},{"issue":"8","key":"10.1016\/j.jaad.2014.10.012_bib16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ophtha.2003.11.013","article-title":"Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%","volume":"111","author":"McCarey","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.jaad.2014.10.012_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2133.2010.09685.x","article-title":"Characterization of an in\u00a0vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost","volume":"162","author":"Tauchi","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0906-6705.2005.00270.x","article-title":"Influence of prostaglandin F2\u03b1 and its analogues on hair regrowth and follicular melanogenesis in a murine model","volume":"14","author":"Sasaki","year":"2005","journal-title":"Exp Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2014.10.012_bib19","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0039-6257(02)00307-7","article-title":"Prostaglandin-induced hair growth","volume":"47","author":"Johnstone","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.jaad.2014.10.012_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1523-1747.2003.12168.x","article-title":"Androgenetic alopecia in women","volume":"8","author":"Price","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"7162","key":"10.1016\/j.jaad.2014.10.012_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.317.7162.865","article-title":"Male pattern androgenetic alopecia","volume":"317","author":"Sinclair","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1096\/fj.12-218156","article-title":"The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias","volume":"27","author":"Khidhir","year":"2013","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib23","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2014.10.012_bib24","first-page":"795","article-title":"Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution","volume":"10","author":"Emer","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"16","key":"10.1016\/j.jaad.2014.10.012_bib25","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jaad.2014.10.012_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","article-title":"Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata","volume":"53","author":"Ross","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2014.10.012_bib27","first-page":"586","article-title":"The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows","volume":"19","author":"Faghihi","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2014.10.012_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","article-title":"Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata","volume":"60","author":"Roseborough","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2014.10.012_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2009.01.027","article-title":"Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata","volume":"61","author":"Ochoa","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0974-7753.77511","article-title":"Bimatoprost in the treatment of eyelash universalis alopecia areata","volume":"2","author":"Vila","year":"2010","journal-title":"Int J Trichology"},{"issue":"4","key":"10.1016\/j.jaad.2014.10.012_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","article-title":"Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis","volume":"24","author":"Coronel-P\u00e9rez","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib32","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0974-7753.90809","article-title":"The role of bimatoprost\u00a0eyelash gel in chemotherapy-induced madarosis: an analysis\u00a0of efficacy and safety","volume":"3","author":"Morris","year":"2011","journal-title":"Int J Trichology"},{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.0022-202X.2004.22516.x","article-title":"Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE and PGF on melanocyte dendricity","volume":"122","author":"Scott","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.yexcr.2004.11.016","article-title":"Effects of PGF2\u03b1 on human melanocytes and regulation of the FP receptor by ultraviolet radiation","volume":"304","author":"Scott","year":"2005","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.jaad.2014.10.012_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","article-title":"Vitiligo: a review of the published work","volume":"38","author":"Yaghoobi","year":"2011","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2014.10.012_bib37","first-page":"350","article-title":"Three cases of vitiligo showing response to application of latanoprost","volume":"48","author":"Noh","year":"2010","journal-title":"Korean J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2014.10.012_bib38","first-page":"109","article-title":"Common pigmentation disorders","volume":"79","author":"Plensdorf","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2014.10.012_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1524-4725.2012.02389.x","article-title":"Repigmentation of hypopigmented scars using an erbium-doped 1,550-nm fractionated laser and topical bimatoprost","volume":"38","author":"Massaki","year":"2012","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2014.10.012_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/IOP.0b013e31817d81df","article-title":"Periorbital changes associated with topical\u00a0bimatoprost","volume":"24","author":"Filippopoulos","year":"2008","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.jaad.2014.10.012_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/01676830.2010.527028","article-title":"Periorbital fat atrophy\u2013an unfamiliar side effect of prostaglandin analogues","volume":"29","author":"Jayaprakasam","year":"2010","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.jaad.2014.10.012_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10384-010-0904-z","article-title":"Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost","volume":"55","author":"Park","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaad.2014.10.012_bib43","unstructured":"US National Institutes of Health Clinical Trials. A safety and efficacy study of bimatoprost in men with androgenic alopecia (AGA). Available from: URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01904721. Accessed August 11, 2014."},{"key":"10.1016\/j.jaad.2014.10.012_bib44","unstructured":"US National Institutes of Health Clinical Trials. Safety and efficacy study of bimatoprost in the treatment of men with androgenic alopecia. Available from: URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01325337. Accessed August 11, 2014."},{"key":"10.1016\/j.jaad.2014.10.012_bib45","unstructured":"US National Institutes of Health Clinical Trials. Safety and pharmacokinetics study of new formulation of bimatoprost in patients with alopecia. Available from: URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01189279. Accessed August 11, 2014."},{"key":"10.1016\/j.jaad.2014.10.012_bib46","unstructured":"US National Institutes of Health Clinical Trials. Safety and efficacy study of bimatoprost in the treatment of women with female pattern hair loss. Available from: URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01325350. Accessed August 11, 2014."},{"key":"10.1016\/j.jaad.2014.10.012_bib47","unstructured":"US National Institutes of Health Clinical Trials. Bimatoprost ophthalmic solution in increasing eyebrow and eyelash growth in patients who have undergone chemotherapy for\u00a0breast cancer and in healthy participants. Available from:\u00a0URL:\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00999557. Accessed August 11, 2014."},{"key":"10.1016\/j.jaad.2014.10.012_bib48","unstructured":"US National Institutes of Health Clinical Trials. Safety and efficacy study of bimatoprost in Japanese patients with chemotherapy-induced eyelash hypotrichosis. Available from: URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01391286. Accessed August 11, 2014."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221402057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221402057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:34:12Z","timestamp":1759271652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221402057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S019096221402057X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.10.012","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising alternative clinical uses of prostaglandin F2\u03b1 analogs: Beyond the eyelashes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}